Nektar Therapeutics (NKTR)

21.41 -0.44  -2.01% NASDAQ Aug 10, 12:01 USD

Nektar Therapeutics Total Long Term Debt (Quarterly):

254.14M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Total Long Term Debt (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Long Term Debt (Quarterly) Data

View and export this data going back to 1994. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 254.14M
Dec. 31, 2019 248.69M
Sept. 30, 2019 248.26M
June 30, 2019 247.82M
March 31, 2019 247.39M
Dec. 31, 2018 246.95M
Sept. 30, 2018 246.51M
June 30, 2018 246.08M
March 31, 2018 245.64M
Dec. 31, 2017 245.21M
Sept. 30, 2017 244.77M
June 30, 2017 244.34M
March 31, 2017 243.90M
Dec. 31, 2016 243.46M
Sept. 30, 2016 243.00M
June 30, 2016 242.57M
March 31, 2016 242.13M
Dec. 31, 2015 241.70M
Sept. 30, 2015 125.00M
June 30, 2015 125.00M
March 31, 2015 125.00M
Dec. 31, 2014 125.00M
Sept. 30, 2014 125.00M
June 30, 2014 125.00M
March 31, 2014 125.00M
   
Dec. 31, 2013 125.00M
Sept. 30, 2013 125.00M
June 30, 2013 125.00M
March 31, 2013 125.00M
Dec. 31, 2012 125.00M
Sept. 30, 2012 125.00M
June 30, 2012 214.96M
March 31, 2012 214.96M
Dec. 31, 2011 214.96M
Sept. 30, 2011 214.96M
June 30, 2011 214.96M
March 31, 2011 214.96M
Dec. 31, 2010 214.96M
Sept. 30, 2010 214.96M
June 30, 2010 214.96M
March 31, 2010 214.96M
Dec. 31, 2009 214.96M
Sept. 30, 2009 214.96M
June 30, 2009 214.96M
March 31, 2009 214.96M
Dec. 31, 2008 214.96M
Sept. 30, 2008 316.40M
June 30, 2008 316.83M
March 31, 2008 317.26M
Dec. 31, 2007 315.00M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Long Term Debt Definition

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Benchmarks

Benchmarks
Intercept Pharmaceuticals Inc 538.97M
ACADIA Pharmaceuticals Inc 0.00
Karyopharm Therapeutics Inc 113.78M

Total Long Term Debt (Quarterly) Range, Past 5 Years

Minimum 125.00M Sep 2015
Maximum 254.14M Mar 2020
Average 239.35M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.